Pharmacoepigenetics in schizophrenia: Predicting drug response
 
Yazarlar (5)
Irmak Dal Ankara University
Doç. Dr. Selin ÖZKAN KOTİLOĞLU Kırşehir Ahi Evran Üniversitesi, Türkiye
Prof. Dr. Bora Baskak Ankara Üniversitesi, Türkiye
Prof. Dr. Dilek Akyüzlü Ankara Üniversitesi, Türkiye
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) (SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale)
Dergi Adı WORLD JOURNAL OF PSYCHIATRY (Q2)
Dergi ISSN 2220-3206 Wos Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 07-2025
Cilt / Sayı / Sayfa 15 / 7 / 107597–0 DOI 10.5498/wjp.v15.i7.107597
Makale Linki https://doi.org/10.5498/wjp.v15.i7.107597
Özet
Individual differences in treatment response in schizophrenia pose a significant challenge in the management of the disease, due to several biological as well as psychosocial factors, including genetic and epigenetic mechanisms. Pharmacoepigenetics investigates how epigenetic mechanisms affect the variability in effectiveness of treatments and adverse side effects. Antipsychotics such as clozapine (atypical) and haloperidol (typical) directly induce epigenetic changes by altering DNA methyltransferases and histone acetyltransferases, while indirectly affecting neuroinflammatory and stress response pathways. Personalized medicine using epigenetic markers (DNA methylation, non-coding RNAs including microRNAs and long non-coding RNAs) holds great promise for improving the drug response and reducing the side effects of antipsychotic treatment. These developments could revolutionize the treatment of …
Anahtar Kelimeler
Pharmacoepigenetics | Treatment failures | Personalized medicine | Antipsychotic drugs | Schizophrenia
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 3
Google Scholar 3
Pharmacoepigenetics in schizophrenia: Predicting drug response

Paylaş